Stabilization of the C-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma.

Ying Gu,Jiawei Zhang,Xiaoxiao Ma,Byung-Wook Kim,Hailong Wang,Jinfan Li,Yi Pan,Yang Xu,Lili Ding,Lu Yang,Chao Guo,Xiwei Wu,Jun Wu,Kirk Wu,Xiaoxian Gan,Gang Li,Ling Li,Stephen J Forman,Wing-Chung Chan,Rongzhen Xu,Wendong Huang

DOI: https://doi.org/10.1016/j.ccell.2017.06.001

IF: 50.3

2017-01-01

Cancer Cell

Abstract:Although high c-Myc protein expression is observed alongside MYC amplification in some cancers, in most cases protein overexpression occurs in the absence of gene amplification, e.g., T cell lymphoma (TCL). Here, Ca2+/calmodulin-dependent protein kinase II γ (CAMKIIγ) was shown to stabilize the c-Myc protein by directly phosphorylating it at serine 62 (S62). Furthermore, CAMKIIγ was shown to be essential for tumor maintenance. Inhibition of CAMKIIγ with a specific inhibitor destabilized c-Myc and reduced tumor burden. Importantly, high CAMKIIγ levels in patient TCL specimens correlate with increased c-Myc and pS62-c-Myc levels. Together, the CAMKIIγ:c-Myc axis critically influences the development and maintenance of TCL and represents a potential therapeutic target for TCL.